{"slideshow_credits": null, "snippet": "In a clinical trial, the drug reduced the risk of having a heart attack or stroke, or of dying from cardiovascular causes by 14 percent.", "abstract": "Study published by The New England Journal of Medicine finds diabetes drug Jardiance reduces overall risk of having heart attack or stroke, or dying from cardiovascular causes, by 14 percent.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/09/18/business/jardiance-a-diabetes-drug-is-shown-to-reduce-cardiovascular-deaths.html", "lead_paragraph": "In a clinical trial, the drug reduced the risk of having a heart attack or stroke, or of dying from cardiovascular causes by 14 percent.", "headline": {"main": "Jardiance, a Diabetes Drug, Cut Cardiovascular Deaths by 38%, Study Says", "print_headline": "Diabetes Drug Cut Cardiovascular Deaths by 38%, Study Says"}, "_id": "55fadff838f0d816d1846a7f", "word_count": "1133", "multimedia": [], "pub_date": "2015-09-18T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Diabetes", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Heart", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Stroke", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Eli Lilly and Company", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Boehringer Ingelheim GmbH", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Research", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}